Antibodies to β-amyloid decrease the blood-to-brain transfer of β-amyloid peptide

Experimental Biology and Medicine

Volumn 227, Issue 8, 2002, Pages 609-615

  Pan, Weihong ^a   Solomon, Beka ^b   Maness, Lawrence M ^a   Kastin, Abba J ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

amyloid peptides; Alzheimer's disease; Antibody; Blood brain barrier; Mice; Vaccine

Indexed keywords

AMYLOID BETA PROTEIN; ANTIBODY; BETA AMYLOID ANTIBODY; IODINE 125; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ARTICLE; BLOOD BRAIN BARRIER; BRAIN PERFUSION; CONTROLLED STUDY; DEMENTIA; DRUG MECHANISM; ISOTOPE LABELING; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN TRANSPORT; SENILE PLAQUE; VASCULAR AMYLOIDOSIS;

AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BLOOD-BRAIN BARRIER; BRAIN; CULTURE MEDIA, SERUM-FREE; IMMUNOGLOBULIN G; INJECTIONS, INTRAVENOUS; MALE; MICE; MICE, INBRED ICR; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PERFUSION;

ANIMALIA;

EID: 0036734997     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Aihara N, Tanno H, Hall JJ, Pitts LH, Noble LJ. Immunocytochemical localization of immunoglobulins in the rat brain: relationship to the blood-brain barrier. J Comp Neurol 342:481-496, 1994.
2. Banks WA, Kastin AJ. Passage of peptides across the blood-brain barrier: pathophysiological perspectives. Life Sci 59:1923-1943, 1996.
3. 1-28 (Alzheimer's disease protein). Brain Res Bull 27:819-823, 1991.
4. Bard F, Cannon C, Barbour R, Burke RL, Games D, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Lieberburg I, Motter R, Nguyen M, Soriano F, Vasquez N, Weiss K, Welch B, Seubert P, Schenk D, Yednock T. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer's disease. Nat Med 6:916-919, 2000.
5. Blasberg RG, Fenstermacher JD, Patlak CS. Transport of α-aminoisobutyric acid across brain capillary and cellular membranes. J Cereb Blood Flow Metab 3:8-32, 1983.
6. DeMattos RB, Bales KR, Cummins DJ, Dodart J-C, Paul SM, Holtzman DM. Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 98:8850-8855, 2001.
7. Fay DS, Fluet A, Johnson CJ, Link CD. In vivo aggregation of β-amyloid peptide variants. J Neurochem 71:1616-1625, 1998.
8. Frenkel D, Balass M, Katchalski-Katzir E, Solomon B. High affinity binding of monoclonal antibodies to the sequential epitope EFRH of β-amyloid peptide is essential for modulation of fibrillar aggregation. J Neuroimmunol 95:136-142, 1999.
9. Frenkel D, Solomon B, Benhar I. Modulation of Alzheimer's β-amyloid neurotoxicity by site-directed single-chain antibody. J Neuroimmunol 106:23-31, 2000.
10. Gutierrez EG, Banks WA, Kastin AJ. Murine tumor necrosis factor-α is transported from blood to brain in the mouse. J Neuroimmunol 47:169-176, 1993.
11. Jancso G, Komoki F, Santha P, Varga J, Fischer J, Orosz K, Penke B, Becskei A, Dux M, Toth L. β-Amyloid(1-42) peptide impairs blood-brain barrier function after intracarotid infusion in rats. Neurosci Lett 253:139-141, 1998.
12. Mackic JB, Stins M, McComb JG, Calero M, Ghiso J, Kim KS, Yan SD, Stern D, Schmidt AM, Frangione B, Zlokovic BV. Human blood-brain barrier receptors for Alzheimer's amyloid-β 1-40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer. J Clin Invest 102:734-743, 1998.
13. Maness LM, Banks WA, Podlisny MB, Selkoe DJ, Kastin AJ. Passage of human amyloid β-protein 1-40 across the murine blood-brain barrier. Life Sci 55:1643-1650, 1994.
14. Morgan D, Diamond DM, Gottschall PE, Ugen KE, Dickey C, Hardy J, Duff K, Jantzen P, DiCarlo G, Wilcock D, Connor K, Hatcher J, Hope C, Gordon M, Arendash GW. Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 408:982-985, 2000.
15. Morley JE, Farr SA, Flood JF. Antibody to amyloid β protein alleviates impaired acquisition, retention and memory processing in SAMP8 mice. Neurobiol Learn Mem 78:125-138, 2002.
16. Pan W, Kastin AJ. Penetration of neurotrophins and cytokines across the blood-brain/blood-spinal cord barrier. Adv Drug Delivery Rev 36:291-298, 1999.
17. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 3:1-7, 1983.
18. Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Lieberburg, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N. Immunization with amyloid-β attenuates Alzheimer's disease-like pathology in the PDAPP mouse. Nature 400:173-177, 1999.
19. Schenk DB, Seubert P, Lieberburg I, Wallace J. β-Peptide immunization: a possible new treatment for Alzheimer's disease. Arch Neurol 57:934-936, 2000.
20. 1-40 peptide from brain by LDL-receptor-related protein-1 at the blood-brain barrier. J Clin Invest 106:1489-1499, 2000.
21. Solomon B, Koppel R, Frankel D, Hanan-Aharon E. Disaggregation of Alzheimer's β-amyloid by site-directed mAb. Proc Natl Acad Sci U S A 94:4109-4112, 1997.
22. Strazielle N, Ghersi-Egea JF, Ghiso J, Dehouck MP, Frangione B, Patlak C, Fenstermacher J, Gorevic P. In vitro evidence that β-amyloid peptide 1-40 diffuses across the blood-brain barrier and affects its permeability. J Neuropathol Exp Neurol 59:29-38, 2000.
23. Su GC, Arendash GW, Kalaria RN, Bjugstad KB, Mullan M. Intravascular infusions of soluble β-amyloid compromise the blood-brain barrier, activate CNS glial cells and induce peripheral hemorrhage. Brain Res 818:105-117, 1999.
24. Triguero D, Buciak J, Pardridge WM. Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins. J Neurochem 54:1882-1888, 1990.
25. Watson DJ, Lander AD, Selkoe DJ. Heparin-binding properties of the amyloidogenic peptides Aβ and amylin. J Biol Chem 272:31617-31624, 1997.